Rodin Therapeutics - Ownership and Business Overview

Life ScienceCompany

Rodin Therapeutics Ownership

Who owns Rodin Therapeutics?

Rodin Therapeutics is owned by Alkermes. It was acquired on November 18, 2019.

Rodin Therapeutics Business Overview

Where is Rodin Therapeutics headquartered?

Rodin Therapeutics is headquartered in Boston, Massachusetts.

What sector is Rodin Therapeutics in?

Rodin Therapeutics is a life science company.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.

Rodin Therapeutics, Inc.

101 Huntington Avenue 21st Floor, Suite 2150,
Boston, Massachusetts 02199
United States,
(617) 581-9333
www.rodintherapeutics.com

Rodin Therapeutics, Inc. is a biopharmaceutical company discovering and developing first-in-class therapeutics by applying novel chemical strategies to target protein complexes that selectively modulate gene expression. Rodin Therapeutics is based in Boston, Massachusetts.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.